Due to health issues, this site is no longer maintained and will be shut down shortly.

DNAC Social Capital Suvretta Holdings Corp. III - Class A

Social Capital Suvretta Holdings Corp. III focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on searching for a target business operating in the biotechnology industry and within the organ space sub-sector. The company was incorporated in 2021 and is based in Henderson, Nevada.

On 1/18/2022 the company announced a proposed merger with ProKidney LP, a leading clinical-stage cellular therapeutics company focused on chronic kidney disease.  

$9.28  -0.72 (-7.20%)
As of 07/11/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  
IPO date:  06/30/2021
Outstanding shares:  25,640,000
Average volume:  338,836
Market cap:   $237,939,200
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy